TITLE

Untitled

PUB. DATE
November 1961
SOURCE
New Yorker;11/25/1961, Vol. 37 Issue 41, p96
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on Merck, Sharp & Dohme, a family drug business in Rahway, New Jersey. It cites that the business dates back to the seventeenth century, started in Darmstadt, Germany in 1668 by Friedrich Jacob Merck. It states that Merck's son, George, has also set-up a small chemical business in Rahway.
ACCESSION #
22798000

 

Related Articles

  • High-dose statins could reduce LDL cholesterol by 55%.  // GP: General Practitioner;1/28/2002, p7 

    Reports on the negation by Merck Sharp and Dohme that it has not applied for a license to treat familial hypercholesterolemia with 120 milligrams of simvastatin in England.

  • Merck Puerto Rico contributes to bulk of company's 2001 rise in sales. Martinez, Marialba // Caribbean Business;4/25/2002, Vol. 30 Issue 17, p16 

    Reports on the financial performance of drug company Merck Sharpe and Dohme Quimica de P.R. in 2001. Contribution of the firm to the sales increase of its parent company; Forecast on the firm's financial performance in 2002; Other growth targets and strategies.

  • Merck Sharp & Dohme Limited.  // Thorax;Dec2008 Supplement 7, Vol. 63, p48 

    The article offers information on Merck Sharp & Dohme Ltd., one of the exhibitors at the British Thoracic Society's winter meeting in London, England in December 2008. Merck is the British subsidiary of New Jersey-based leading research-based pharmaceutical company Merck & Co. The firm...

  • A long, toxic way to Tipperary. Payne, Doug // New Scientist;1/5/91, Vol. 129 Issue 1750, p16 

    Reports that the final chapter of a legal battle that could affect the chemicals industry throughout Europe is about to start at the Dublin High Court. Hanrahan vs. Merck Sharpe & Dohme; History of the case; Changes in health of family and deaths of animals after drug manufacturer opens...

  • Cipla to co-market MSD's raltegravir tablet.  // BioSpectrum;Mar2014, Vol. 12 Issue 3, p18 

    The article focuses on an India-specific strategic partnership between Merck Sharp & Dohme Ltd. (MSD), noted to be one of the world's key players in HIV innovative treatment and Cipla Ltd., a pharmaceutical company.

  • Wanda Gonzales: a true industry leader.  // Caribbean Business;4/15/2004, Vol. 32 Issue 17, pPR13 

    Features Wanda Gonzalez, an executive at Merck, Sharp & Dohme, and recipient of a Manufacturing Manager of the Year Award from the Puerto Rico Manufacturers Association (PRMA). Initiatives established by Gonzalez as director of tablet operations of the pharmacuetical company; Efforts to achieve...

  • $25 million hazardous waste system by Merck. Johnston, Robert D. // Caribbean Business;10/19/1995, Vol. 23 Issue 42, p39 

    Describes pharmaceutical firm Merck Sharp & Dohme's construction of an incinerator system specifically for hazardous waste generated at its Barcenolata plant in Puerto Rico. Amount invested by the company in the project.

  • Sun Pharma calls off Merck deal.  // Telegraph (Calcutta, India);2/13/2016, p12 

    The article reports that Sun Pharmaceutical Industries Ltd. and Merck Sharp and Dohme Ltd. (MSD) have decided not to make further investments in the joint venture that they planned to set up to provide generic drugs to emerging markets outside India.

  • For Daneris Fernández, hard work is key to success. May, Jonathan // Caribbean Business;7/27/2006, Vol. 34 Issue 29, pW7 

    The article profiles Daneris Fernández, vice president of the Manufacturing Division of Merck, Sharp & Dohme Corp., a pharmaceutical company in Puerto Rico. Other positions that she held in the company include technical services manager and contract operations director. She had worked hard to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics